June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Comparison of Outcomes of Trifocal and Extended-depth-of-focus Intraocular Lenses
Author Affiliations & Notes
  • Madeleine Puig
    Ophthalmology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
  • Yousef Salem
    Ophthalmology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
  • Maria Morrow
    Ophthalmology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
  • Corey Waldman
    Ophthalmology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
  • Footnotes
    Commercial Relationships   Madeleine Puig None; Yousef Salem None; Maria Morrow None; Corey Waldman None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1706 – F0024. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Madeleine Puig, Yousef Salem, Maria Morrow, Corey Waldman; Comparison of Outcomes of Trifocal and Extended-depth-of-focus Intraocular Lenses. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1706 – F0024.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate and compare distance and near visual acuity, spectacle independence, and visual disturbances of the trifocal intraocular lens Acrysof Panoptix and the extended-depth-of-focus lenses Acrysof Vivity, Tecnis Eyhance, and Tecnis Symfony.

Methods : One hundred and twenty-seven eyes of 68 patients who underwent bilateral or unilateral cataract surgery with implantation of the non-toric or toric Acrysof Panoptix, Acrysof Vivity, Tecnis Eyhance, and Tecnis Symfony IOL between 2019 and 2021 were included in this retrospective study. Eyes with pre-existing ocular comorbidities were included in this study and 23 eyes undergoing concurrent glaucoma surgery. Pre- and postoperative corrected visual acuities, spectacle independence and visual disturbances were collected and analyzed. Descriptive statistics (mean and standard deviation) were calculated for all visual acuities. Comparison of more than two groups was performed using the Kruskal-Wallis test, non-parametric type of the one-way analysis of variance, and Chi-squared test. P values of 0.05 or less were considered to be statistically significant in all cases.

Results : No statistically significant differences were noted in the best corrected distance visual acuity (BCDVA) after surgery between the cohorts (p-value = 0.3302, Kruskal-Wallis test p<0.05). However, there was a significant difference between the best corrected near visual acuity (BCNVA) after surgery between the four cohorts (p=0.00497, Kruskal-Wallis test, p<0.05). The Symfony lens had the best average BCNVA. There was no statistical difference for spectacle independence at distance between the cohorts (p = 0.247; Chi-squared test p<0.05). However, the rate of spectacle independence at near between the four cohorts was significantly different (the p-value is < 0.00001, Chi-squared test) and Panoptix has the greatest proportion of spectacle independence. There wasn’t a significant difference between the cohorts in regards to visual disturbances (p-value =.06127, Chi-squared test p<0.05)

Conclusions : All lenses were similarly effective in visual acuity and spectacle independence with minimal visual disturbances at distance. However, at near, each lens has its own advantages and disadvantages and the preference of each patient should be considered when selecting a trifocal or extended-depth-of-focus lens.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×